Minnesota Becomes 23rd State to Legalize Adult-Use Marijuana, Including Delta-8 THC

Jun 2, 2023 | News

Minnesota recently joined the ranks of states that have legalized adult-use marijuana, making it the 23rd state in the U.S. to do so. Governor Tim Walz signed a groundbreaking legalization bill into law on Tuesday, which not only allows the use of marijuana but also permits the sale of hemp-derived cannabinoids like delta-8 THC.  Below is an overview of Minnesota’s unique approach to legalization, the implementation timeline, and the state’s progressive stance on hemp-derived products.

Legislative Legalization and Governor’s Support

Minnesota is one of a growing number of states that have legalized cannabis through the legislative process rather than relying on ballot initiatives. Unlike some states that allow citizen-initiated ballot questions, Minnesota does not permit this method of legalization. The legislation was signed by Governor Tim Walz, who was joined by cannabis advocates and former Minnesota Governor Jesse Ventura, a prominent supporter of legalization.

Key Provisions of the New Law

Effective from August 1st, Minnesotans aged 21 and over will be legally allowed to possess and cultivate cannabis. The law also imposes a 10% tax on marijuana sales. However, the issuance of the first retail business licenses by the newly established Office of Cannabis Management is expected to take approximately one year. This delay ensures the necessary regulations and infrastructure are in place for a successful launch of the state’s adult-use market.

Minnesota’s Unique Stance on Hemp-Derived Cannabinoids

What sets Minnesota apart from other states is its inclusive approach to hemp-derived cannabinoids, particularly delta-8 THC. While 14 states have banned or strictly regulated such products due to concerns over competition with regulated cannabis industries, Minnesota welcomes their inclusion in the mainstream state-legal cannabis industry. The state has introduced a “mezzobusiness” license that allows holders to cultivate, manufacture, and operate up to three retail locations selling marijuana and products containing hemp-derived cannabinoids.

Local Control and Medical Marijuana Operators

Although there is no statewide license cap, localities have the authority to limit the number of dispensaries to one per 12,500 residents. This provision ensures that the establishment of cannabis businesses aligns with the preferences and needs of individual communities. Furthermore, Minnesota’s medical marijuana operators, currently limited to just two multistate companies, will be permitted to enter the adult-use market, expanding the industry and increasing consumer choice.

THC-Infused Drinks and the Testing Ground

Minnesota’s new law also positions the state as a testing ground for THC-infused drinks. Liquor and convenience stores will be allowed to sell these products, presenting an opportunity for innovative cannabis entrepreneurs to explore this emerging market segment. THC-infused drinks have gained popularity in the state since their legalization for sale a year ago alongside other hemp-derived cannabinoid-infused products.

Conclusion

With the legalization of adult-use marijuana, including the sale of hemp-derived cannabinoids like delta-8 THC, Minnesota has become the 23rd state to embrace cannabis reform. By taking a legislative approach and involving key stakeholders, the state aims to establish a well-regulated market that ensures public safety and generates tax revenue. Minnesota’s progressive stance on hemp-derived products, along with its allowance for medical marijuana operators to participate in the adult-use market, signals a promising future for the cannabis industry in the state.

Original Source: Mjbizdaily

Publisher/Reporter: Chris Roberts

Publish Date: May 30, 2023

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

by | May 4, 2023 | News | 0 Comments

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Missouri Division of Cannabis Regulation Initiates Recall of 62,000 Cannabis Products: An In-Depth Look at the Delta Extraction Case and Industry Lessons

by | September 6, 2023 | Education, News | 0 Comments

The Missouri Division of Cannabis Regulation (DCR) has recently taken a significant step in the cannabis industry by issuing a recall of more than 62,000 cannabis products manufactured by Delta Extraction, LLC. The reason behind this recall lies in the fact that these products were not being compliantly tracked in the statewide track and trace system known as METRC. This failure to adhere to tracking protocols created a situation where the DCR could not verify the origins of these products – whether they were sourced from marijuana cultivated within Missouri and had undergone the necessary testing procedures.

Cannabis Acceptance Surges Despite the Growing Illicit Market

by | October 4, 2023 | Education, News | 0 Comments

In a more current assessment, recent research suggests that the public’s embrace of cannabis is steadily increasing, even as the illicit market maintains its presence. This study, conducted by New Frontier Data, a prominent cannabis consulting firm, involved surveys of nearly 4,400 cannabis consumers and 1,200 nonusers across the United States. The findings reveal a noteworthy surge in acceptance and consumption of cannabis over the past year.

Revolutionary Shift: US Health Department Proposes Reclassifying Marijuana from Schedule I to Schedule III

by | September 1, 2023 | News | 0 Comments

In a groundbreaking move that has the potential to reshape the landscape of cannabis regulations, the U.S. Department of Health and Human Services (HHS) has taken a bold step by formally recommending the reclassification of marijuana from Schedule I to Schedule III under federal law. This historic decision signifies a seismic shift in perspective, indicating that the nation’s premier health agency no longer views cannabis as a substance with high abuse potential and zero medical value.

Newsletter